Direct Comparison of Human Mesenchymal Stem Cells Derived from Adipose Tissues and Bone Marrow in Mediating Neovascularization in Response to Vascular Ischemia
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND/AIM: Although transplantation of MSC derived from bone marrow or adipose tissues has been shown in proangiogenic action in hindlimb ischemia model of nude mice, little information is available regarding comparison of the angiogenic potency between human adipose stromal cells (hADSC) and bone marrow stromal cells (hBMSC). We compared their therapeutic potential by transplantation of equal numbers of hADSC or hBMSC in a nude mice model of hindlimb ischemia. METHODS AND RESULTS: One day after creating hindlimb ischemia, mice were randomized to receive hADSC transplantation (hADSC group), hBMSC transplantation (hBMSC group), or vehicle transplantation (Control group). Two weeks after transplantation, the laser Doppler perfusion index was significantly higher in the hADSC group and hBMSC group than in the control group. Comparison between hADSC and hBMSC group showed better recovery of blood flow in hADSC group than in hBMSC group. Conditioned media from hADSC (hADSC-CM) showed better in vitro tube formation of hADSC than conditioned media from hBMSC (hBMSC-CM). hADSC showed higher expression of MMP3 and MMP9 than hBMSC. A MMP inhibitor, GM6001, and the transfection of MMP3 or MMP9 siRNA oligonucleotides inhibited in vitro tube formation of hADSC. Transplantation of MMP3 or MMP9 siRNA oligonucleotieds-transfected hADSC showed lower blood flow recovery and higher tissue injury than control oligonucelotide-transfected cells. CONCLUSION: This study showed that hADSC can be an ideal source for therapeutic angiogenesis in ischemic disease in terms of efficacy, accessibility and available tissue amounts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although our results align with previous studies showing superior proangiogenic abilities [41] and higher secretion of VEGF in BM-MSC cultures [42], others have conversely reported higher tube formation and angiogenic bioactivity in the secretome of A-MSCs [43, 44].”
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
Zuk, P. A., Zhu, M., Mizuno, H., Huang, J., Futrell, J. W., Katz, A. J., Benhaim, P., Lorenz, H. P., & Hedrick, M. H. (2001) · Tissue Engineering · doi:10.1089/107632701300062859 · Cited by 7,956
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
Mechanisms of angiogenesis and arteriogenesis
Carmeliet, P. (2000) · Nature Medicine · doi:10.1038/74651 · Cited by 4,162
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Kinnaird, T., Stabile, E., Burnett, M. S., Lee, C. W., Barr, S., Fuchs, S., & Epstein, S. E. (2004) · Circulation Research · doi:10.1161/01.res.0000118601.37875.ac · Cited by 1,415
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Baker, A. H., Edwards, D. R., & Murphy, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00063 · Cited by 1,179
Cited by
Strioga, M., Viswanathan, S., Darinskas, A., Slaby, O., & Michalek, J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0722 · Cited by 825
“compared MSCs isolated from bone marrow, adipose tissue, and umbilical cord and found that BM-MSCs had the lowest proliferative capacity (in terms of both proliferation rates and number of cell doublings), while umbilical cord-derived MSCs showed the highest proliferation potency [112]; (3) differentiation potential,…”
Biological functions of mesenchymal stem cells and clinical implications
Naji, A., Eitoku, M., Favier, B., Deschaseaux, F., Rouas-Freiss, N., & Suganuma, N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03125-1 · Cited by 624
Clinical applications of mesenchymal stem cells
Wang, S., Qu, X., & Zhao, R. C. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-19 · Cited by 483
“MMP3, MMP9 mediating neovascularization [49]”
Zheng, G., Huang, L., Tong, H., Shu, Q., Hu, Y., Ge, M., Deng, K., Zhang, L., Zou, B., Cheng, B., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-39 · Cited by 428
“They were significantly better than BM-MSCs in inhibiting both the differentiation of blood monocytes into dendritic cells as defined by CD83 expression and the expression of co-stimulatory molecules (CD80, CD86) on the surface of mature monocyte-derived dendritic cells.”
BackgroundInfluentialHsiao, S. T.-F., Asgari, A., Lokmic, Z., Sinclair, R., Dusting, G. J., Lim, S. Y., & Dilley, R. J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0674 · Cited by 410
“In addition, ASCs have been shown to exhibit greater therapeutic potential than BMSCs in attenuating murine brain ischemic injury [24] and improving limb perfusion recovery postischemia in a murine hindlimb ischemia model [25].”
InfluentialRafei, M., Campeau, P. M., Aguilar-Mahecha, A., Buchanan, M., Williams, P., Birman, E., Yuan, S., Young, Y. K., Boivin, M.-N., Forner, K., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803962 · Cited by 381
Kim, Y. J., Hwang, S. J., Bae, Y. C., & Jung, J. S. (2009) · Stem Cells · doi:10.1002/stem.235 · Cited by 373
Self-citationGealekman, O., Guseva, N., Hartigan, C., Apotheker, S., Gorgoglione, M., Gurav, K., Tran, K.-V., Straubhaar, J., Nicoloro, S., Czech, M. P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.970145 · Cited by 346
Transplantation of adipose tissue and stem cells: role in metabolism and disease
Tran, T. T., & Kahn, C. R. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.20 · Cited by 330
Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis
Riordan, N. H., Ichim, T. E., Min, W.-P., Wang, H., Solano, F., Lara, F., Alfaro, M., Rodriguez, J. P., Harman, R. J., Patel, A. N., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-29 · Cited by 324
Bura, A., Planat-Benard, V., Bourin, P., Silvestre, J.-S., Gross, F., Grolleau, J.-L., Saint-Lebese, B., Peyrafitte, J.-A., Fleury, S., Gadelorge, M., et al. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2013.11.011 · Cited by 297
“Although ASCs share many features with BMMSCs, they display a stronger angiogenic and regenerative potential when compared in an identical experimental setting of a CLI model to BM-MSC administration (15,16).”
BackgroundCell-based strategies for IVD repair: clinical progress and translational obstacles
Binch, A. L. A., Fitzgerald, J. C., Growney, E. A., & Barry, F. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00568-w · Cited by 296
Trophic Effects of Mesenchymal Stem Cells in Tissue Regeneration
Fu, Y., Karbaat, L., Wu, L., Leijten, J., Both, S. K., & Karperien, M. (2017) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2016.0365 · Cited by 276
“…their multilineage differentiation capacity, MSCs have shown to be capable of reducing inflammation by modulating the immune system, 28–35 promoting angiogenesis, 36–40 and inducing cell migration, proliferation, 41–44 differentiation, and extracellular matrix (ECM) formation 39,45,46 (Table 1).”
Acellular and cellular approaches to improve diabetic wound healing
Cho, H., Blatchley, M. R., Duh, E. J., & Gerecht, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.019 · Cited by 257
Self-citationMesenchymal Stem Cells Derived from Human Adipose Tissues Favor Tumor Cell Growth in vivo
Yu, J. M., Jun, E. S., Bae, Y. C., & Jung, J. S. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0181 · Cited by 271
“Recently, we demonstrated that hASCs evidenced proangiogenic action superior to that of hBMSCs [30].”
Self-citationRufaihah, A. J., Huang, N. F., Jamé, S., Lee, J. C., Nguyen, H. N., Byers, B., De, A., Okogbaa, J., Rollins, M., Reijo-Pera, R., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.230938 · Cited by 263
Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells
Gimble, J. M., Guilak, F., & Bunnell, B. A. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt19 · Cited by 261
“In stroke models, ASC infusion during the immediate postischemic period accelerated recovery of motor function in rats [ 44-46 ].”
BackgroundKim, Y. J., Bae, S. W., Yu, S. S., Bae, Y. C., & Jung, J. S. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081230 · Cited by 250
Self-citationStonesifer, C., Corey, S., Ghanekar, S., Diamandis, Z., Acosta, S. A., & Borlongan, C. V. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.07.004 · Cited by 241
“AD-MSCs have also been found to reduce cell death, slowing the rate of apoptosis and improving recovery in the cerebral infract of rats with ischemic stroke (Kim et al., 2007; Gutierrez-Fernandez et al., 2013; Leu et al., 2010).”
Chu, D.-T., Phuong, T. N. T., Tien, N. L. B., Tran, D. K., Thanh, V. V., Quang, T. L., Truong, D. T., Pham, V. H., Ngoc, V. T. N., Chu-Dinh, T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030708 · Cited by 236
“Remodeling of extracellular matrix Metalloproteinase 9 (MMP9) [52]”
BackgroundAdipose-derived stromal cells: their identity and uses in clinical trials, an update
Casteilla, L. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i4.25 · Cited by 235
Altman, A. M., Yan, Y., Matthias, N., Bai, X., Rios, C., Mathur, A. B., Song, Y.-H., & Alt, E. U. (2009) · Stem Cells · doi:10.1634/stemcells.2008-0178 · Cited by 232
Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells
Liao, H.-T. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i3.288 · Cited by 229
Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases
Volkman, R., & Offen, D. (2017) · Stem Cells · doi:10.1002/stem.2651 · Cited by 222
Cho, H. H., Shin, K. K., Kim, Y. J., Song, J. S., Kim, J. M., Bae, Y. C., Kim, C. D., & Jung, J. S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22024 · Cited by 180
“Kosaka et al. (2000) suggested that activation of NF-kB may enhance the osteoblastic differentiation of undifferentiated mesenchymal cells in spinal ligaments.”
BackgroundSelf-citationIohara, K., Zheng, L., Ito, M., Ishizaka, R., Nakamura, H., Into, T., Matsushita, K., & Nakashima, M. (2009) · Regenerative Medicine · doi:10.2217/rme.09.5 · Cited by 169
Adipose Tissue-Derived Stem Cells and Their Application in Bone and Cartilage Tissue Engineering
Rada, T., Reis, R. L., & Gomes, M. E. (2009) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2008.0423 · Cited by 164
“This research group investigated the capacity to promote neovascularization in nude mice, showing that a better neovascularization was observed with ASCs, in both the cases, that is, when the neovascularization was induced by the transdifferentiation of the cells into endothelial cells and by the release of VEGF and b…”
Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer
Plava, J., Cihova, M., Burikova, M., Matuskova, M., Kucerova, L., & Miklikova, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0960-z · Cited by 164
Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis
Burchfield, J. S., & Dimmeler, S. (2008) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-1-4 · Cited by 163
“Using a hind limb ischemia model, one study suggested that MSCs isolated from adipose tissue have a greater angiogenic capacity than MSCs isolated from bone marrow [82], and these cells had higher expression levels of MMP-3 and MMP-9.”
Methodde Girolamo, L., Lucarelli, E., Alessandri, G., Antonietta Avanzini, M., Ester Bernardo, M., Biagi, E., Teresa Brini, A., D’Amico, G., Fagioli, F., Ferrero, I., et al. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319130015 · Cited by 161
“Some studies show that adipose-derived MSCs are more angiogenic than bone marrow-derived cells (BMSCs) [30], display their proliferative capacity for long period [26, 31] and retain for longer time their adipogenic capacity [18, 32].”
Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia
Liew, A., & O'Brien, T. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt119 · Cited by 161
“[17] Human AT-MSCs and human BM-MSCs Mouse IM injection of 1 × 106 MSCs 24 hours after HLI Gastrocnemius, gracilis, and quadriceps ↑ limb perfusion, ↓ muscle injury”
BackgroundMethodResultInfluentialTherapeutic potential of adipose-derived stem cells in vascular growth and tissue repair
Hong, S. J., Traktuev, D. O., & March, K. L. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e328334f074 · Cited by 155
Tissue engineering approaches for bone repair: Concepts and evidence
Schroeder, J. E., & Mosheiff, R. (2011) · Injury · doi:10.1016/j.injury.2011.03.029 · Cited by 171
New strategies to optimize kidney recovery and preservation in transplantation
Bon, D., Chatauret, N. P., Giraud, S., Thuillier, R., Favreau, F. D., & Hauet, T. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.83 · Cited by 138
Intra-Articular Injections in Knee Osteoarthritis: A Review of Literature
Testa, G., Giardina, S. M. C., Culmone, A., Vescio, A., Turchetta, M., Cannavò, S., & Pavone, V. (2021) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk6010015 · Cited by 164
“Adipose-derived stromal cells (ADSCs) share many features with bone marrow stem cells, such as paracrine activity [46] and strong angiogenic activity [47,48].”
BackgroundKim, Y. J., Hwang, S. H., Cho, H. H., Shin, K. K., Bae, Y. C., & Jung, J. S. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22716 · Cited by 136
Self-citationMesenchymal stem cell therapy and acute graft-versus-host disease: a review
Amorin, B., Alegretti, A. P., Valim, V., Pezzi, A., Laureano, A. M., da Silva, M. A. L., Wieck, A., & Silla, L. (2014) · Human Cell · doi:10.1007/s13577-014-0095-x · Cited by 133
“Matrix metalloproteinases 3 and 9 (MMP3, MMP9) Mediate neovascularization [137]”
Backgroundvan der Bogt, K. E. A., Schrepfer, S., Yu, J., Sheikh, A. Y., Hoyt, G. E., Govaert, J. A., Velotta, J. B., Contag, C. H., Robbins, R. C., & Wu, J. C. (2009) · Transplantation · doi:10.1097/tp.0b013e31819609d9 · Cited by 137
“In fact, it has even been proposed that human ASC are superior to MSC with regard to their paracrine and angiogenic potential in response to ischemia (33).”
BackgroundHamdi, H., Planat‐Benard, V., Bel, A., Puymirat, É., Geha, R., Pidial, L., Nematalla, H., Bellamy, V., Bouaziz, P., Peyrard, S., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr099 · Cited by 139
Li, J., Zhang, Q., Wang, W., Lin, F., Wang, S., & Zhao, J. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10138-5 · Cited by 128
Bortolotti, F., Ukovich, L., Razban, V., Martinelli, V., Ruozi, G., Pelos, B., Dore, F., Giacca, M., & Zacchigna, S. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.01.001 · Cited by 118
“, who attributed a higher angiogenic and therapeutic potential to AT-MSCs in comparison to MSCs of BM origin (Kim et al., 2007).”
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
Rogers, C. J., Harman, R. J., Bunnell, B. A., Schreiber, M. A., Xiang, C. C., Wang, F., Santidrián, A. F., & Minev, B. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02380-2 · Cited by 120
Aging and Diabetes Impair the Neovascular Potential of Adipose-Derived Stromal Cells
El‐ftesi, S., Chang, E. I.-F., Longaker, M. T., & Gurtner, G. C. (2009) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181954d08 · Cited by 118
Immunomodulatory Effects of Adipose-Derived Stem Cells: Fact or Fiction?
Barone, A. A. L., Khalifian, S., Lee, W. P. A., & Brandacher, G. (2013) · BioMed Research International · doi:10.1155/2013/383685 · Cited by 124
“Importantly, the use of human ASCs was found to be superior to human BM-MSCs at salvaging ischemic hind limbs, further promoting the use of ASCs in this setting [74].”
BackgroundKalbermatten, D. F., Schaakxs, D., Kingham, P. J., & Wiberg, M. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1142-5 · Cited by 108
Kocan, B., Maziarz, A., Tabarkiewicz, J., Ochiya, T., & Banaś-Ząbczyk, A. (2017) · Stem Cells International · doi:10.1155/2017/1653254 · Cited by 108
Tobita, M., Uysal, Ç. A., Guo, X., Hyakusoku, H., & Mizuno, H. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.05.007 · Cited by 107
Isolation, Characterization, Differentiation, and Application of Adipose-Derived Stem Cells
Kuhbier, J. W., Weyand, B., Radtke, C., Vogt, P. M., Kasper, C., & Reimers, K. (2010) · Springer eBooks · doi:10.1007/10_2009_24 · Cited by 112
“The same workgroup found an essential role of MMP for vessel formation in an additional study in 2007 [145].”
BackgroundMohammed, E., Khalil, E., & Sabry, D. (2018) · Biomolecules · doi:10.3390/biom8040167 · Cited by 99
“However, it represents a minor trophic effect, as they have superior secretion of a wide range of bioactive molecules, enhancing the endogenous regeneration by different cell types’ migration, differentiation, and proliferation, including fibroblasts, endothelial, and epithelial cells [28], a superior angiogenic effec…”
BackgroundPaduano, F., Marrelli, M., Amantea, M., Rengo, C., Rengo, S., Goldberg, M., Spagnuolo, G., & Tatullo, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102140 · Cited by 103
“When compared to bone marrow stromal cells (BMSCs), ASCs show higher proangiogenic activities, mediated by the matrix metalloproteinases MMP-3 and MMP-9 [25].”
Kuchroo, P., Dave, V., Vijayan, A., Viswanathan, C., & Ghosh, D. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0184 · Cited by 94
“Nevertheless, MSCs isolated from various tissues exhibit inherent differences [32,45,46] as well as difference in their potential to induce neovascularization [47,48].”
BackgroundBarros, S. D., Dehez, S., Arnaud, E., Barreau, C., Cazavet, A., Perez, G., Galinier, A., Casteilla, L., & Planat-Bénard, V. (2013) · Molecular Therapy · doi:10.1038/mt.2012.213 · Cited by 91
Kim, E. K., Li, G., Lee, T. J., & Hong, J. P. (2011) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e31821e6de2 · Cited by 92
Brennan, M. Á., Renaud, A., Guilloton, F., Mebarki, M., Trichet, V., Sensebé, L., Deschaseaux, F., Chevallier, N., & Layrolle, P. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0133 · Cited by 95
Silk Fibroin-Based Therapeutics for Impaired Wound Healing
Lehmann, T., Vaughn, A. E., Seal, S., Liechty, K. W., & Zgheib, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030651 · Cited by 91
“These BM-MSCs have been reported to enhance wound healing through expression of keratin and the formation of both vascular and glandular structures [54,65].”
BackgroundLu, H., Wang, F., Mei, H., Wang, S., & Cheng, L. (2018) · Stem Cells International · doi:10.1155/2018/7537589 · Cited by 86
Widgerow, A. D., Salibian, A. A., Lalezari, S., & Evans, G. R. D. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23284 · Cited by 86
“…from ADSCs and BMSCs have shown that the two groups have similar gene expression characteristics (Taghi et al., 2012) and also express comparable levels of particular growth factors such as VEGF, ciliary neurotrophic factor (CNTF), and NGF (Kim et al., 2007; Hsiao et al., 2012; Taghi et al., 2012).”
BackgroundMesenchymal Stem Cell Therapy for Ischemic Tissues
Yong, K. W., Choi, J. R., Mohammadi, M., Mitha, A. P., Sanati‐Nezhad, A., & Sen, A. (2018) · Stem Cells International · doi:10.1155/2018/8179075 · Cited by 88
“It was found that hMSCs isolated from adipose tissues express a high level of MMP-3 and MMP-9, which may increase the release of VEGF, enabling hMSCs to efficiently differentiate into endothelial cells [69].”
BackgroundZhu, Q., Li, Q., Niu, X., Zhang, G., Ling, X., Zhang, J., Wang, Y., & Deng, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490214 · Cited by 73
Mesenchymal stem cell delivery strategies to promote cardiac regeneration following ischemic injury
Russo, V., Young, S., Hamilton, A., Amsden, B. G., & Flynn, L. E. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.01.075 · Cited by 78
“capacity [40]and immunomodulation [41e43]”
Ammar, H. I., Sequiera, G. L., Nashed, M., Ammar, R. I., Gabr, H. M., Elsayed, H. E., Sareen, N., Abu‐El‐Rub, E., Zickri, M. B., & Dhingra, S. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0142-x · Cited by 78
“In various pre-clinical and clinical studies, AT-MSCs and BMMSCs have comparable outcomes [27, 28].”
Liu, X., Wang, Z., WANG, R., Zhao, F., Shi, P., Jiang, Y., & Pang, X. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1199 · Cited by 76
“Among numerous progenitor cell types reported to have potential in the development of tissue engineering products, mesenchymal stem cells (MSCs) have been proposed as a prominent candidate (4).”
Secretome of Senescent Adipose-Derived Mesenchymal Stem Cells Negatively Regulates Angiogenesis
Ratushnyy, A. Y., Ездакова, М. И., & Buravkova, L. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051802 · Cited by 76
Sarveazad, A., Newstead, G. L., Mirzaei, R., Joghataei, M. T., Bakhtiari, M., Babahajian, A., & Mahjoubi, B. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0489-2 · Cited by 70
Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia
Beltrán-Camacho, L., Rojas-Torres, M., & Durán-Ruiz, M. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052335 · Cited by 69
“MSCs can be isolated from bone marrow, peripheral blood, or adipose tissues, and from them we can obtain osteoblasts, chondrocytes, adipocytes, neurons, endothelial cells (ECs), skeletal muscle cells, and vascular smooth muscle cells (VSMCs) [97].”
BackgroundHashemian, S. J., Kouhnavard, M., & Nasli‐Esfahani, E. (2015) · Journal of Diabetes Research · doi:10.1155/2015/675103 · Cited by 73
“To date, evidences show that MSCs have immunomodulatory effects on T lymphocytes (T cells), B lymphocytes (B cells), dendritic cells (DCs), and natural killer cells (NK cells).”
BackgroundYan, J., Tie, G., Xu, T., Cecchini, K. R., & Messina, L. M. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9433-8 · Cited by 69
“In contrast, transplantation of human adipose tissue-derived MSCs showed better blood flow recovery in preclinical models of hindlimb ischemia [31].”
BackgroundIm, G. (2017) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36089 · Cited by 64
Enhanced wound vascularization using a dsASCs seeded FPEG scaffold
Zamora, D. O., Natesan, S., Becerra, S. C., Wrice, N. L., Chung, E., Suggs, L. J., & Christy, R. J. (2013) · Angiogenesis · doi:10.1007/s10456-013-9352-y · Cited by 60
“For example, ASCs have been shown to successfully enhance revascularization of ischemic hind limbs in mice over such other cells types as human mesenchymal stem cells (MSCs) from bone marrow [19].”
Mesenchymal Stromal Cells for Cardiovascular Repair: Current Status and Future Challenges
Mathiasen, A. B., Haack‐Sørensen, M., & Kastrup, J. (2009) · Future Cardiology · doi:10.2217/fca.09.42 · Cited by 59
“In a mouse hindlimb ischemia model, ADSCs and BMMSCs were compared and the results suggest that ADSCs are more potent than BMMSCs [68].”
ResultQayyum, A. A., Mathiasen, A. B., Mygind, N. D., Kühl, J. T., Jørgensen, E. O., Helqvist, S., Elberg, J. J., Kofoed, K. F., Vejlstrup, N. G., Fischer‐Nielsen, A., et al. (2017) · Stem Cells International · doi:10.1155/2017/5237063 · Cited by 59
Calcat-i-Cervera, S., Rendra, E., Scaccia, E., Amadeo, F., Hanson, V., Wilm, B., Murray, P., O’Brien, T., Taylor, A., & Bieback, K. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03352-1 · Cited by 56
“BM-MSCs exhibited the longest doubling time as well as the highest interdonor variability, whereas A-MSCs consistently showed the least donor-to-donor variation regardless of where they were cultured.”
ResultInfluentialJayaram, P., Ikpeama, U. E., Rothenberg, J. B., & Malanga, G. A. (2018) · PM&R · doi:10.1016/j.pmrj.2018.06.019 · Cited by 68
“There are in vivo studies that demonstrate superior angio-inductive properties of ADSCs than BMSCs in ischemic models; however, this has not been tested and proven in OA models [55].”
ResultHe, J., Genetos, D. C., Yellowley, C. E., & Leach, J. K. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22514 · Cited by 63
“whose actions recruit and stabilize developing vasculatures [Kim et al., 2007; Rubina et al., 2009].”
BackgroundMesenchymal Stromal Cells Based Therapy in Systemic Sclerosis: Rational and Challenges
Peltzer, J., Aletti, M., Frescaline, N., Busson, É., Lataillade, J., & Martinaud, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02013 · Cited by 56
Conese, M., Annacontini, L., Carbone, A., Beccia, E., Cecchino, L. R., Parisi, D., Gioia, S. D., Lembo, F., Angiolillo, A., Mastrangelo, F., et al. (2020) · Stem Cells International · doi:10.1155/2020/7056261 · Cited by 66
“Finally, meanwhile BM-MSCs are more committed towards the osteoblastic and chondrogenic lineages, ASCs are prone to stimulate angiogenesis [36, 37].”
BackgroundKang, M., Kim, H.-S., You, J., Choi, Y. S., Kwon, B., Park, C. H., Baek, W., Kim, M. S., Lee, Y. J., Im, G., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay5413 · Cited by 57
“Previous studies have reported that the proangiogenic activity of ADSCs is driven partly by their endothelial differentiation and is higher than that of BMSCs in a mouse model of hindlimb ischemia (13).”
BackgroundSelf-citationSkiles, M. L., Sahai, S., Rucker, L. R., & Blanchette, J. O. (2013) · Tissue Engineering Part A · doi:10.1089/ten.tea.2012.0750 · Cited by 57
Vériter, S., Aouassar, N., Adnet, P.-Y., Paridaens, M., Stuckman, C., Jordan, B. F., Karroum, O., Gallez, B., Gianello, P., & Dufrane, D. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.061 · Cited by 55
Aird, A. L., Nevitt, C. D., Christian, K., Williams, S. K., Hoying, J. B., & LeBlanc, A. J. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.01.044 · Cited by 53
Human Adipose Tissue-Derived Stromal Cell Therapy Prevents Bone Loss in Ovariectomized Nude Mouse
Cho, S. W., Sun, H. J., Yang, J., Jung, J. Y., Choi, H. J., An, J. H., Kim, S. W., Kim, S. Y., Park, K.-J., & Shin, C. S. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0355 · Cited by 55
“17 We previously performed syngeneic murine BMMSC mediated gene therapy for preventing bone loss in ovariectomized mice 18,19 and confirmed that MSCs could clearly protect against overiectomy (OVX)-induced bone loss in these animals, 18 although the mechanism for this positive effect still remained…”
Self-citationAhmadzadeh, N., Robering, J. W., Kengelbach‐Weigand, A., Al‐Abboodi, M., Beier, J. P., Horch, R. E., & Boos, A. M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111816 · Cited by 50
Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia
Shirbaghaee, Z., Hassani, M., Keshel, S. H., & Soleimani, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03148-9 · Cited by 53
“They may have greater therapeutic implications and a lower probability of allogenic transplantation rejection [121]. hPSC-MSCs may represent the most encouraging patient-specific cell source for stem cell therapy due to their unlimited self-renewal and differentiation capacity toward MSCs [122]. iPSC-MSCs surpassed BM…”
BackgroundInfluentialRole of adipose mesenchymal stem cells and secretome in peripheral nerve regeneration
Sumarwoto, T., Suroto, H., Mahyudin, F., Utomo, D. N., Romaniyanto, Tinduh, D., Notobroto, H. B., Prakoeswa, C. R. S., Rantam, F. A., & Rhatomy, S. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102482 · Cited by 59
Lv, Z., Cai, X., Bian, Y., Wei, Z., Zhu, W., Zhao, X., & Weng, X. (2023) · Bioengineering · doi:10.3390/bioengineering10020195 · Cited by 56
“Stud‐ ies have demonstrated that MSCs extracted from the amniotic membrane and fat are su‐ perior to those collected from bone marrow, and MSCs sourced from umbilical cord blood show the weakest immunosuppressive potential [29,30].”
InfluentialAltman, A. M., Gupta, V., Ríos, C. N., Alt, E., & Mathur, A. B. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.10.034 · Cited by 48
Kim, J. Y., Shin, K. K., Lee, A. L., Kim, Y. S., Park, H. J., Park, Y. K., Bae, Y. C., & Jung, J. S. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.344 · Cited by 48
“The hADSCs were isolated according to the methods described in previous studies.(55) hADSCs were maintained in low-glucose DMEM with 10% fetal bovine serum, 100mg/ml streptomycin and 100 U/ml penicillin in 5% CO2 environment at 37 1C.”
MethodSelf-citationBrennan, M. Á., Renaud, A., Guilloton, F., Mebarki, M., Trichet, V., Sensebé, L., Deschaseaux, F., Chevallier, N., & Layrolle, P. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.12274 · Cited by 49
Paitazoglou, C., Bergmann, M., Vrtovec, B., Chamuleau, S. A. J., van Klarenbosch, B., Wojakowski, W., Michalewska‐Włudarczyk, A., Gyöngyösi, M., Ekblond, A., Haack‐Sørensen, M., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1412 · Cited by 47
Hong, S. J., Hou, D., Brinton, T. J., Johnstone, B. H., Feng, D., Rogers, P. I., Fearon, W. F., Yock, P. G., & March, K. L. (2012) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.24659 · Cited by 51
Kappos, E. A., Engels, P. E., Tremp, M., zu Schwabedissen, M. M., di Summa, P. G., Fischmann, A., von Felten, S., Scherberich, A., Schaefer, D. J., & Kalbermatten, D. F. (2015) · Stem Cells and Development · doi:10.1089/scd.2014.0424 · Cited by 46
“Here again, human bone marrow-derived stem cells (hBMSCs) were compared with human adipose-derived stem cells (hASCs): In a nude mice model of hind limb ischemia, hASCs exhibited greater proangiogenic activity than hBMSCs [20,21].”
Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety
Rodríguez, J. P., Murphy, M. P., Hong, S. J., Madrigal, M., March, K. L., Minev, B., Harman, R. J., Chen, C.-S., Timmons, R. B., Marleau, A. M., et al. (2012) · International Archives of Medicine · doi:10.1186/1755-7682-5-5 · Cited by 47
“MSC expanded from adipose tissue are equivalent, if not superior to bone marrow in terms of differentiation ability [41,42], angiogenesis stimulating potential [43,44], and immune modulatory effects [45].”
BackgroundKim, H. K., Kim, Y. J., Kim, J., Kwon, C. H., Kim, Y. K., Bae, Y. C., Kim, D. H., & Jung, J. S. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0141 · Cited by 50
“We reported that culture-expanded hASCs have a proangiogenic action in a hindlimb ischemia model [16] and that hASCs transplantation showed better blood fl ow recovery than BMSCs transplantation [17].”
Self-citationSarveazad, A., Babahajian, A., Bakhtiari, M., Soleimani, M., Behnam, B., Yari, A., Akbari, A., Yousefifard, M., Janzadeh, A., Amini, N., et al. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.07.004 · Cited by 46
“, 2009), matrixmetalloproteinase (essential for nerve growth and ECMrearrangement) (Kim et al., 2007) and VEGF (key angiogenesis factor in functional recovery) (Rehman et al.”
BackgroundNeovascularization: The Main Mechanism of MSCs in Ischemic Heart Disease Therapy
Shi, W., Xin, Q., Yuan, R., Yuan, Y., Cong, W., & Chen, K. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.633300 · Cited by 50
“(20) observed that conditioned medium from human AMSCs showed better tube formation-promoting effects than that from BMSCs in vitro, and AMSC group showed better recovery of blood flow than BMSC group in hindlimb ischemia model of nude mice.”
BackgroundAraña, M., Peña, E., Abizanda, G., Cilla, M., Ochoa, I., Gavira, J. J., Espinosa, G., Doblaré, M., Pelacho, B., & Prósper, F. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.12.014 · Cited by 48
Navarro, A., Marín, S., Riol, N., Carbonell‐Uberos, F., & Miñana, M. D. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt438 · Cited by 48
“In this study, mesenchymal stromal cells (MSCs) derived from adipose SVF, known to be angiogenic in animal models of ischemia [17,18], the nonhematopoietic CD45 cell component of the SVF, and blood CD14 monocytes were used as controls in these investigations.”
MethodMesenchymal Stem Cells Modifications for Enhanced Bone Targeting and Bone Regeneration
Safarova, Y., Umbayev, B. A., Hortelano, G., & Askarova, S. (2020) · Regenerative Medicine · doi:10.2217/rme-2019-0081 · Cited by 49
Application of Adipose-Derived Stem Cells in Heart Disease
Chen, L., Qin, F., Ge, M., Shu, Q., & Xu, J. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9585-1 · Cited by 44
“Therefore, ASCs have a greater angiogenic potential than BM-MSCs and may be more effective in cardiovascular pathologies associated with ischemia [101].”
BackgroundAdipose Tissue–Derived Stem Cells Enhance Bioprosthetic Mesh Repair of Ventral Hernias
Altman, A. M., Khalek, F. J. A., Alt, E., & Butler, C. E. (2010) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181e6044f · Cited by 43
Metadata
- Authors
- Kim, Y. J., Kim, H. K., Cho, H. H., Bae, Y. C., Suh, K. T., & Jung, J. S.
- Affiliations
- Pusan National University (KR)
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 20
- Issue
- 6
- Pages
- 867-876
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2075222271
- Cited by
- 298
- References
- 32
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 10 · 2023: 15 · 2022: 9 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 23 · 2017: 22 · 2016: 23 · 2015: 11 · 2014: 22 · 2013: 18 · 2012: 21
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cellular Physiology and Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- human adipose-derived stem cells, mesenchymal stem cells, therapeutic angiogenesis, hindlimb ischemia, neovascularization, MMP-3, MMP-9, conditioned medium, tube formation, GM6001, siRNA knockdown, cell transplantation, laser Doppler perfusion
- MeSH terms
- Adipose Tissue, Adult, Animals, Bone Marrow Cells, Cells, Cultured, Collagen, Dipeptides, Drug Combinations, Gene Expression Regulation, Humans, Ischemia, Laminin, Male, Mice, Inbred BALB C, Mice, Nude, Middle Aged, Proteoglycans, Neovascularization, Physiologic, Matrix Metalloproteinase 3, Matrix Metalloproteinase 9, RNA, Small Interfering, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.